Rigel Pharmaceuticals rises after upbeat results

Rigel Pharmaceuticals

03/05/2023 12:00

** Shares of drugmaker Rigel Pharmaceuticals Inc  RIGL.O 
rise 4.4% to $1.19 premarket
    ** Reports smaller-than-expected Q1 loss of $0.08 vs
estimates of loss of $0.10 per share - Refinitiv data
    ** Q1 revenue rises to $26.1 mln from $16.7 mln a yr ago,
and beats estimates of $24.1 mln
    ** Rev gets boost from higher sales of bleeding disorder
drug, Tavalisse
    ** Up to last close, stock had fallen 24% so far this year

 (Reporting by Ashwini Raj in Bengaluru)
 ((Ashwini.Raj@thomsonreuters.com))